Colon carcinoma in situ

Summary

Colon carcinoma in situ (MONDO:0004663) is a cancer. A subtype of colon carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	colon carcinoma in situ
Mondo ID	MONDO:0004663
DOID	DOID:8826
ICD-10-CM	D01.0
ICD-11	1958429829
NCIT	C3638
SNOMED CT	92568009
UMLS	C0154061
MedGen	56334
Anatomy (UBERON)	UBERON:0001155
Is cancer (heuristic)	yes

Also known as: carcinoma in situ of colon · carcinoma in situ of the colon · colon cancer stage 0 · colon carcinoma in situ · colon in situ carcinoma · colonic carcinoma in situ · stage 0 carcinoma of colon · stage 0 carcinoma of the colon · stage 0 colon cancer · stage 0 colon cancer aJCC v6 · stage 0 colon cancer aJCC v6 and v7 · stage 0 colon cancer aJCC v7 · stage 0 colon carcinoma · stage 0 colonic carcinoma

Disease family

This is a subtype of colon carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › large intestine disorder › colonic disorder › colonic neoplasm › malignant colon neoplasm › colon carcinoma › colon carcinoma in situ

Related subtypes (5): colon adenocarcinoma, rectosigmoid carcinoma, colon small cell neuroendocrine carcinoma, cecum carcinoma, squamous cell carcinoma of colon

Subtypes (1): carcinoma in situ of cecum

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.